Coronary heart disease primary prevention: Revision history

10 January 2013

• curprev 19:5519:55, 10 January 2013‎ Michael Maddaleni talk contribs‎ 17,930 bytes +2‎ →‎Treatment of Triglycerides
• curprev 19:4919:49, 10 January 2013‎ Michael Maddaleni talk contribs‎ 17,928 bytes −1‎ →‎CV Risk Factors in the Setting of Primary Prevention

8 January 2013

• curprev 16:3616:36, 8 January 2013‎ Prashanthsaddala talk contribs‎ 17,929 bytes +36‎ No edit summary

6 January 2013

• curprev 16:0416:04, 6 January 2013‎ Charmaine Patel talk contribs‎ 17,893 bytes +40‎ →‎Overview
• curprev 16:0216:02, 6 January 2013‎ Charmaine Patel talk contribs‎ 17,853 bytes +317‎ →‎Overview
• curprev 15:5915:59, 6 January 2013‎ Charmaine Patel talk contribs‎ 17,536 bytes +264‎ No edit summary
• curprev 15:5615:56, 6 January 2013‎ Charmaine Patel talk contribs‎ 17,272 bytes −4‎ →‎Treat Underlying Causes of Hyperlipidemia

4 January 2013

• curprev 21:3621:36, 4 January 2013‎ Prashanthsaddala talk contribs‎ 17,276 bytes +25‎ No edit summary
• curprev 21:2821:28, 4 January 2013‎ Prashanthsaddala talk contribs‎ 17,251 bytes −4‎ →‎Treat Underlying Causes of Hyperlipidemia

26 November 2012

• curprev 16:0916:09, 26 November 2012‎ Maheep Sangha talk contribs‎ 17,255 bytes +2,566‎ /* ACC / AHA 2012 Guidelines - Coronary Heart Disease - Identification of Patients at Risk for Coronary Heart Disease{{cite journal| author=2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR et al.| title=2012 AC...

10 October 2012

• curprev 15:1515:15, 10 October 2012‎ Esther Lee talk contribs‎ 14,689 bytes +28‎ /* ACC / AHA Guidelines for Identification of Patients at Risk for Coronary Heart Disease{{cite journal| author=2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR et al.| title=2012 ACCF/AHA Focused Update of the...

9 October 2012

• curprev 16:5416:54, 9 October 2012‎ Esther Lee talk contribs‎ 14,661 bytes −1‎ /* ACC / AHA Guidelines for Identification of Patients at Risk for Coronary Heart Disease{{cite journal| author=2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR et al.| title=2012 ACCF/AHA Focused Update of the...
• curprev 16:4816:48, 9 October 2012‎ Esther Lee talk contribs‎ 14,662 bytes +1,725‎ No edit summary

1 October 2012

• curprev 05:1805:18, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,937 bytes +301‎ →‎Treatment of Triglycerides
• curprev 05:1505:15, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,636 bytes +173‎ →‎Treatment of Triglycerides
• curprev 05:1205:12, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,463 bytes +351‎ →‎Avoid Drugs that Cause Dyslipidemia
• curprev 05:0805:08, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,112 bytes +369‎ →‎Avoid Drug Interactions with the LDL-Lowering Agents Simvastatin, Atorvastatin or Lovastatin
• curprev 05:0005:00, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,743 bytes +22‎ →‎Avoid Drug Interactions with the LDL-Lowering Agents Simvastatin, Atorvastatin or Lovastatin
• curprev 04:5304:53, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,721 bytes +6‎ →‎Drug Interactions with the LDL-Lowering Agents Simvastatin, Atorvastatin or Lovastatin
• curprev 04:5304:53, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,715 bytes +1‎ →‎Drug Interactions with the LDL-Lowering Agents Simvastatin, Atorvastatin or Lovastatin
• curprev 04:5204:52, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,714 bytes +163‎ →‎Drug Interactions with the LDL-Lowering Agents Simvastatin, Atorvastatin or Lovastatin
• curprev 04:5004:50, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,551 bytes +6‎ →‎Drugs that Cause Dyslipidemia
• curprev 04:4904:49, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,545 bytes 0‎ No edit summary
• curprev 04:4704:47, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,545 bytes +20‎ →‎Lifestyle Modification Goals
• curprev 04:4704:47, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,525 bytes +320‎ →‎Drug Interactions with the LDL-Lowering Agents Simvastatin, Atorvastatin or Lovastatin
• curprev 04:4304:43, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,205 bytes +266‎ →‎Primary Prevention: LDL Goals for Various Categories of RiskExpert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001; 285:2486-2497
• curprev 04:3704:37, 1 October 2012‎ C Michael Gibson talk contribs‎ 10,939 bytes −1,944‎ No edit summary
• curprev 04:3404:34, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,883 bytes −1‎ →‎Lifestyle Modification Goals
• curprev 04:3404:34, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,884 bytes +616‎ →‎Lifestyle Modification Goals
• curprev 04:3404:34, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,268 bytes −1,402‎ →‎Exercise
• curprev 04:3204:32, 1 October 2012‎ C Michael Gibson talk contribs‎ 13,670 bytes −525‎ →‎Modification of Risk Factors that do not have a Robust Evidence Base
• curprev 04:3104:31, 1 October 2012‎ C Michael Gibson talk contribs‎ 14,195 bytes +10‎ →‎Lifestyle Modification Goals
• curprev 04:2504:25, 1 October 2012‎ C Michael Gibson talk contribs‎ 14,185 bytes 0‎ →‎Modification of Risk Factors that do not have a Robust Evidence Base
• curprev 04:2504:25, 1 October 2012‎ C Michael Gibson talk contribs‎ 14,185 bytes +1,980‎ →‎Modification of Risk Factors that do not have a Robust Evidence Base
• curprev 04:2404:24, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,205 bytes −2,002‎ No edit summary
• curprev 04:2304:23, 1 October 2012‎ C Michael Gibson talk contribs‎ 14,207 bytes 0‎ →‎Drugs that Cause Dyslipidemia
• curprev 04:2304:23, 1 October 2012‎ C Michael Gibson talk contribs‎ 14,207 bytes +316‎ →‎Treat Underlying Causes of Hyperlipidemia
• curprev 04:1804:18, 1 October 2012‎ C Michael Gibson talk contribs‎ 13,891 bytes +389‎ No edit summary
• curprev 04:1304:13, 1 October 2012‎ C Michael Gibson talk contribs‎ 13,502 bytes +1,462‎ No edit summary
• curprev 03:5903:59, 1 October 2012‎ C Michael Gibson talk contribs‎ 12,040 bytes +429‎ →‎Overview
• curprev 03:5403:54, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,611 bytes +12‎ →‎Overview
• curprev 03:5303:53, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,599 bytes +12‎ No edit summary
• curprev 03:5303:53, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,587 bytes +63‎ No edit summary
• curprev 03:4803:48, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,524 bytes +12‎ →‎Overview
• curprev 03:4603:46, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,512 bytes +84‎ →‎Overview
• curprev 03:4303:43, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,428 bytes +1‎ →‎Overview
• curprev 03:4303:43, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,427 bytes 0‎ No edit summary
• curprev 03:4103:41, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,427 bytes 0‎ No edit summary
• curprev 03:4103:41, 1 October 2012‎ C Michael Gibson talk contribs‎ 11,427 bytes +243‎ No edit summary

26 August 2012

• curprev 16:4516:45, 26 August 2012‎ Charmaine Patel talk contribs‎ 11,184 bytes +11,184‎ Created page with "__NOTOC__ {{Coronary heart disease}} {{CMG}} ==Overview== ==Prevention== Coronary heart disease is the most common form of heart disease in the Western world. Prevention cen..."